Overview
- Description
TILT Biotherapeutics is a clinical-stage biotechnology company developing novel gene therapies for cancer. The Company’s patented technology is about oncolytic immunotherapies that modify the tumor microenvironment and eliminates its ability to suppress immune responses to cancer. This therapeutic approach supports the enhancement of combination T cell therapies such as checkpoint inhibitors and CAR T and TIL therapies.
- Website
- Founded
2013
- Project
- Country
- Finland
- Theme
- Healthcare